Stem cell debate could alter European decision-making
This article was originally published in Clinica
Executive Summary
Angry exchanges are taking place in the European corridors of power because the Council considered a compromise on human embryonic stem cell research proposed by the Danish Presidency in the context of the sixth Framework Programme (FP6), a five-year research programme, without consulting the Parliament.